High-Dose Convalescent Plasma for Treatment of Severe COVID-19.
De Santis GC, Oliveira LC, Garibaldi PMM, Almado CEL, Croda J, Arcanjo GGA, Oliveira ÉAF, Tonacio AC, Langhi DM Jr, Bordin JO, Gilio RN, Palma LC, Santos EV, Haddad SK, Prado BPA Jr, Pontelli MC, Gomes R, Miranda CH, Auxiliadora Martins M, Covas DT, Arruda E, Fonseca BAL, Calado RT.
De Santis GC, et al. Among authors: calado rt.
Emerg Infect Dis. 2022 Mar;28(3):548-555. doi: 10.3201/eid2803.212299. Epub 2022 Jan 26.
Emerg Infect Dis. 2022.
PMID: 35081022
Free PMC article.
Clinical Trial.